Adjuvant Chemotherapy with Traditional Chinese Herbal Granules Versus Placebo in Resected Non-Small Cell Lung Cancer: Updated Survival Analysis of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Key Points
Survival analysis indicates improved outcomes with adjuvant chemotherapy using traditional Chinese herbal granules.
Key evidence reveals a significant difference in survival rates between the treatment and placebo groups.
This multicenter, randomized, double-blind, placebo-controlled trial assessed the effectiveness of herbal granules in lung cancer patients.
Findings may enable further exploration of traditional remedies in modern treatments, highlighting potential benefits.
Adjuvant Chemotherapy with Traditional Chinese Herbal Granules Versus Placebo in Resected Non-Small Cell Lung Cancer: Updated Survival Analysis of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial | Synapse